Blockchain Registration Transaction Record
GeoVax CEO to Discuss Innovative Cancer Therapies at ROTH Healthcare Conference
GeoVax Labs, Inc. CEO to join panel on cancer therapies at ROTH Healthcare Conference. The company's lead clinical program involves a next-generation COVID-19 vaccine and a gene-directed therapy for advanced head and neck cancers.
This news matters as it highlights GeoVax Labs, Inc.'s efforts in developing novel vaccines for infectious diseases and therapies for solid tumor cancers, including a next-generation COVID-19 vaccine and a gene-directed therapy for advanced head and neck cancers. The participation of their CEO in the panel discussion signifies the company's commitment to advancing innovative treatments for life-threatening diseases.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xb70ec34065cdf5bd3f8941dbfdae7e4d79192ae7444f3edc3a5e5092352b2eb3 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | larkwsll-c30ffafc7322c0d0a30d2da6cad587a0 |